Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$151.26 USD
-2.17 (-1.41%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $151.34 +0.08 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -1.51 |
EPS Last Quarter | -2.05 |
Last EPS Surprise | -33.12% |
ABR | 1.17 |
Earnings ESP
|
4.60% |
---|---|
Current Year | -7.30 |
Next Year | -4.29 |
EPS (TTM) | -9.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 107.09M | 103.98M | 366.61M | 619.25M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 228.18M | 137.39M | 463.46M | 780.55M |
Low Estimate | 67.27M | 89.10M | 311.62M | 522.35M |
Year ago Sales | 52.02M | 148.62M | 288.27M | 366.61M |
Year over Year Growth Est. | 105.86% | -30.04% | 27.18% | 68.91% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.51 | -1.53 | -7.30 | -4.29 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -1.96 | -1.72 | -7.46 | -4.81 |
High Estimate | 0.66 | -0.85 | -4.73 | -3.02 |
Low Estimate | -2.12 | -1.96 | -8.38 | -5.51 |
Year ago EPS | -3.12 | -1.66 | -9.24 | -7.30 |
Year over Year Growth Est. | 51.60% | 7.83% | 21.00% | 41.20% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 2 | 1 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 3 | 0 | 2 | 0 |
Down Last 30 Days | 4 | 5 | 7 | 6 |
Down Last 60 Days | 5 | 5 | 7 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.51 | -1.53 | -7.30 | -4.29 |
7 Days Ago | -1.10 | -1.56 | -6.83 | -3.82 |
30 Days Ago | -1.36 | -0.75 | -5.60 | -1.83 |
60 Days Ago | -1.29 | -0.67 | -5.57 | -1.70 |
90 Days Ago | -1.29 | -0.67 | -5.40 | -1.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.44 | -1.67 | -7.27 | -4.41 |
Zacks Consensus Estimate | -1.51 | -1.53 | -7.30 | -4.29 |
Earnings ESP | 4.60% | -8.90% | 0.35% | -2.80% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.05 | -2.48 | -1.66 | -3.12 | NA |
Estimate | -1.54 | -1.57 | -2.15 | -2.63 | NA |
Difference | -0.51 | -0.91 | 0.49 | -0.49 | -0.36 |
Surprise | -33.12% | -57.96% | 22.79% | -18.63% | -21.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more